Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value
$158.25M
Total Bought
$53.08M
Total Sold
$32.22M
Net Transaction
+$20.85M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ADMA BIOLOGICS INC1,870,0001,870,000020,90737,38123.62%+16,475
JAZZ PHARMACEUTICALS PLC US LISTED(JAZZ)055,000+55,00006,1283.87%+6,128
ROYALTY PHARMA PLC(RPRX)0212,000+212,00005,9973.79%+5,997
ZEVRA THERAPEUTICS INC(ZVRA)0700,000+700,00004,8583.07%+4,858
EVOLUS INC(EOLS)1,657,6111,369,821-287,79017,98522,19114.02%+4,206
VERASTEM INC(VSTM)01,310,287+1,310,28703,9182.48%+3,918
IRONWOOD PHARMACEUTICALS INC(IRWD)48,0121,000,000+951,9883134,1202.60%+3,807
UROGEN PHARMA LTD(URGN)0280,345+280,34503,5602.25%+3,560
ESTABLISHMENT LABS HOLDINGS(ESTA)075,000+75,00003,2452.05%+3,245
ACADIA PHARMACEUTICALS INC5,000196,895+191,895813,0281.91%+2,947
DAY ONE BIOPHARMACEUTICALS I
COM
0205,675+205,67502,8651.81%+2,865
INDIVIOR PLC0270,000+270,00002,6331.66%+2,633
RIGEL PHARMACEUTICALS INC(RIGL)305,000309,100+4,1002,5075,0013.16%+2,494
GALAPAGOS NV(LKFT)485,000478,659-6,34112,01813,7818.71%+1,762
SCPHARMACEUTICALS INC421,703778,874+357,1711,8343,5522.24%+1,717
OPTINOSE INC2,350,0105,688,590+3,338,5802,4443,8112.41%+1,367
EXAGEN INC(XGN)358,697534,398+175,7016531,6511.04%+998
ARCUTIS BIOTHERAPEUTICS INC(ARQT)088,457+88,45708230.52%+823
PARAGON 28 INC0114,724+114,72407660.48%+766
KIORA PHARMACEUTICALS INC(KPRX)0202,400+202,40007410.47%+741
ACLARIS THERAPEUTICS INC(ACRS)1,927,4462,458,873+531,4272,1202,8281.79%+708
SURROZEN INC(SRZN)66,084110,000+43,9167241,3180.83%+594
KEZAR LIFE SCIENCES INC1,050,4521,491,305+440,8536301,1530.73%+523
ANIKA THERAPEUTICS INC165,397189,308+23,9114,1904,6762.95%+486
POLYPID LTD(PYPD)0138,504+138,50404760.30%+476
MYOMO INC(MYO)0100,000+100,00004010.25%+401
ITEOS THERAPEUTICS INC030,000+30,00003060.19%+306
TENAX THERAPEUTICS INC(TENX)050,000+50,00001730.11%+173
ADICET BIO INC609,446609,44607378780.55%+140
VIRACTA THERAPEUTICS INC0500,000+500,00001160.07%+116
ALIMERA SCIENCES INC CVR02,408,469+2,408,4690960.06%+96
2SEVENTY BIO INC100,000100,00003854720.30%+87
MILESTONE PHARMACEUTICALS IN(MIST)1,239,199999,790-239,4091,6361,5200.96%-116
TELA BIO INC(TELA)625,6451,110,000+484,3552,9412,8081.77%-132
APREA THERAPEUTICS INC(APRE)137,174137,17405583770.24%-181
AYTU BIOPHARMA INC472,469500,958+28,4891,3801,1770.74%-202
ETON PHARMACEUTICALS INC(ETON)110,0000-110,0003620—-362
XOMA CORP250,129195,096-55,0335,9265,1663.26%-759
KIORA PHARMACEUTICALS INC200,0000-200,0008400—-840
AURINIA PHARMACEUTICALS INC(AUPH)300,0000-300,0001,7130—-1,713
REVANCE THERAPEUTICS INC2,800,000820,000-1,980,0007,1964,2562.69%-2,940
ALIMERA SCIENCES INC3,511,8160-3,511,81619,5260—-19,526
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q3 2024 | TickerTrail